"It's very difficult to try to time COVID vaccine before an oncoming surge. And so I think what we're left with is trying to time it with the respiratory virus season, and think about uptake at the same time as folks are getting their flu vaccines," the CDC's Dr. Ruth Link-Gelles...
With a vaccine, it's a little different than a therapy, because this is going to be given to people who are presumably healthy, who don't actually have COVID-19. So that changes the balance somewhat for us. So we-- we've listed a couple of criteria that recently came out in the ...
the medical case for boosters is now compelling. A recent studyfoundthe effectiveness of the mRNA vaccine’s in protecting you from getting COVID went down dramatically from 88 percent to 48 percent at six months, and J&J’s one-dose vaccine’s effectiveness declined to 13 percent. ...
Throughout the COVID-19 pandemic, the FDA has played a critical role in addressing public health concerns by encouraging practices to minimize infectious disease spread and expediting approval for prevention and treatment. In a recentpress announcementfrom Peter Marks, MD, PhD, the direc...
FDA recommends update to COVID vaccine against latest strain ABC News chief medical correspondent Dr. Jen Ashton explains the recommendations from the FDA to update vaccines against the latest COVID-19 strain, which will likely have mutated by winter. ...
The FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, the day after an advisory committee concluded it was safe and effective. Janssen’s Ad26.COV2.S vaccine has been authorised for use in people a
The proposal comes as boosters have become a hard sell. While more than 80% of the U.S. population has had at least one vaccine dose, only 16% of those eligible have received thelatest boostersauthorized in August. The FDA will ask its panel of outside vaccine experts to weigh in at ...
The US Food and Drug Administration (FDA) "will not delay, but will not cut corners" in approving a covid-19 vaccine, its commissioner Stephen Hahn promised a Senate hearing on 23 September, setting up a potential confrontation with President Trump. Any decision will be made by the agency'...
In its analysis of Pfizer's data, the FDA said that rates of hospitalization and death due to COVID-19 among children under 5 were higher than among those aged 5 to 17, "underscoring the benefit of an effective COVID-19 vaccine in this age group." ...
WASHINGTON, Feb. 4 (Xinhua) -- The U.S. Centers for Disease Control and Prevention (CDC) on Friday endorsed recommendation from its vaccine advisers for use of the Moderna COVID-19 vaccine for people ages 18 years and older. The recommendation came after the U.S. Food and Drug Administr...